Ørsted (ORSTED) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
26 Oct, 2026Financial performance review
Audited 2025 Annual Report approved; EBITDA was DKK 22.4bn and adjusted EBITDA DKK 25.1bn; net profit was DKK 3.1bn and return on capital employed 5.4%.
Gross investments totaled DKK 55bn, mainly in offshore wind; net debt fell to DKK 19bn.
DKK 60bn rights issue completed to strengthen the capital structure and maintain an investment-grade rating.
Board and executive committee updates
Rasmus Errboe became CEO in February 2025; an asset project committee was established to monitor risk.
Lene Skole and Andrew Brown re-elected Chair and Deputy Chair; Julia King and Julian David Waldron re-elected, while Karen Dyrskjøt Boesen, Karl Johnny Hersvik, and Samuel Leupold joined the Board.
2025 Remuneration Report and 2026 Board remuneration approved; Board remuneration remained unchanged, and executive STI and LTI scores were 45.9% and 20% of maximum.
Board and Executive Board discharged from liability.
Dividend announcements
No dividend for FY2025; intention to reinstate dividends for 2026, subject to AGM approval.
Latest events from Ørsted
- Adjusted EBITDA grew, but US impairments drove a Q3 loss as offshore projects advanced.ORSTED
Q3 2026 - Adjusted EBITDA beat guidance as the reset plan prioritizes value-led growth and balance-sheet resilience.ORSTED
Q4 2023 (Media) - 2023 EBITDA guidance of DKK 20bn–23bn rests on renewable recovery amid hedge and project risks.ORSTED
Guidance - Portfolio reset targets 35–38 GW of renewables by 2030 with tighter risk controls.ORSTED
Q4 2023 & Capital Markets Update - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - EBITDA to surpass DKK 28 bn in 2026, with major investments and US-driven impairments.ORSTED
Pre-Close Call Presentation - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025